Relapsed or Refractory Peripheral T Cell Lymphoma

Explore clinical trials studying Relapsed or Refractory Peripheral T Cell Lymphoma. Study availability and eligibility vary by location and protocol.

3 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Relapsed or Refractory Peripheral T Cell Lymphoma trial results

Not Yet Recruiting

NCT07615283

Conditions: Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +14 more
Locations: Sun Yat-sen University Cancer Center Guangzhou, China

Not Yet Recruiting

NCT07288814

Conditions: Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
Locations: Not specified

Completed

NCT04105010

Conditions: Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
Locations: Yale Cancer Center New Haven, Connecticut, United States

Winship Cancer Institute Atlanta, Georgia, United States

Washington University School of Medicine St Louis, Missouri, United States

The University of Texas MD Anderson Cancer Center Houston, Texas, United States

View all 50 locations